The Florida dialysis centers market size is expected to reach USD 1.3 billion by 2030, expanding at a CAGR of 5.61% during the forecast period, based on a new report by Grand View Research, Inc. The growth is attributed to increasing R&D investments by medical device companies and the increasing prevalence of CKD. According to the American Kidney Fund, around 48,215 individuals in the state are suffering from ESRD. Of these, 34,847 residents depend on dialysis to stay alive; the remaining 13,368 have undergone kidney transplants.
The rising demand for dialysis units across Florida is an important factor anticipated to boost the market growth over the forecast period. Thus, the introduction of new dialysis facilities in Florida is expected to fuel market growth. For instance, in January 2022 , U.S. Renal Care announced the launch of four more facilities as part of the ongoing expansion of its in-center hemodialysis services in Southwest Florida. With the introduction of three additional clinics, U.S. Renal Care now has a total of seven clinics in the region.
The COVID-19 pandemic negatively impacted the Florida dialysis center market. Several cases of COVID-19 were causing complications such as kidney conditions, leading to shorter patient treatment times as well as a decline in staff & supply shortages that were impeding access to life-sustaining treatments. The impact of COVID-19 on people with kidney disorders led to the first drop in the number of patients on dialysis in the U.S. in the 50-year history of the Medicare ESRD Program.
Request a free sample copy or view report summary: Florida Dialysis Centers Market Report
Based on modality, the in-center segment dominated the market in 2022 owing to the increased prevalence of End-stage Renal Disease (ESRD) and CKD has offered an opportunity for major players to expand their positions in in-center dialysis
Based on dialysis type, the hemodialysis segment held a majority of the market share in 2022 owing to the increasing demand for dialysis due to the clinical advantages of this technique, including the shorter process time and growing adoption of Arteriovenous (AV) fistula
Based on facility type, dialysis chain is the fastest growing segment in 2022 owing to the increasing number of outpatient dialysis facilities has doubled, with free-standing dialysis units
Furthermore, companies in the region are undertaking various strategic initiatives, such as partnerships, mergers & acquisitions, expansions, and new product launches to strengthen their market positions
For instance, in the U.S., DaVita owns or manages more than 2,800 outpatient dialysis centers and offers acute inpatient dialysis services at more than 900 hospitals. As of April 2023, DaVita owns or manages more than 200 outpatient dialysis centers in Florida
Grand View Research has segmented the Florida dialysis centers market based on modality, dialysis type, and facility type:
Florida Dialysis Centers Modality Outlook (Revenue, USD Million, 2018 - 2030)
In-Center
In-Home
SNF-based
Florida Dialysis Centers Dialysis Type Outlook (Revenue, USD Million, 2018 - 2030)
Hemodialysis
Peritoneal Dialysis
Florida Dialysis Centers Facility Type Outlook (Revenue, USD Million, 2018 - 2030)
Dialysis Chains
Independent Facilities
Hospital-based
List of Key Players in the Florida Dialysis Centers Market
South Florida Dialysis Center
Fresenius Medical Care
Central Florida Kidney Centers, INC.
Mayo Clinic Dialysis Center
UF Health Dialysis Center
U.S. Renal Care, Inc.
Florida Kidney Physicians (American Renal Association Boca)
DaVita, Inc.
Crown Dialysis Center of Palm Beach
Universal Kidney Centers
Innovative Renal Care
ARC Dialysis
"The quality of research they have done for us has been excellent..."